UnknownPHASE1, PHASE2NCT00357617

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

Studying Squamous cell carcinoma of oral cavity and lip

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre Hospitalier Universitaire Vaudois
Principal Investigator
Francois Luthi, MD
Centre Hospitalier Universitaire Vaudois
Intervention
celecoxib(drug)
Enrollment
24 enrolled
Eligibility
18 years · All sexes
Timeline
2006

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00357617 on ClinicalTrials.gov

Other trials for Squamous cell carcinoma of oral cavity and lip

Additional recruiting or active studies for the same condition.

See all trials for Squamous cell carcinoma of oral cavity and lip

← Back to all trials